Tumor-infiltrating lymphocyte (TIL) therapy is a promising cancer treatment that harnesses the body’s immune system to fight cancer cells. Developed by Iovance Biotherapeutics, this one-time treatment offers hope for patients with relapsed, unresectable or metastatic melanoma who have exhausted traditional therapies.

For more information, or to refer a patient for TIL Therapy, please call 404-255-1930.